104 related articles for article (PubMed ID: 38875333)
1. Ultrasensitive and multiplexed tracking of single cells using whole-body PET/CT.
Nguyen HTM; Das N; Ricks M; Zhong X; Takematsu E; Wang Y; Ruvalcaba C; Mehadji B; Roncali E; Chan CKF; Pratx G
Sci Adv; 2024 Jun; 10(24):eadk5747. PubMed ID: 38875333
[TBL] [Abstract][Full Text] [Related]
2. Efficient and multiplexed tracking of single cells using whole-body PET/CT.
Nguyen HTM; Das N; Wang Y; Ruvalcaba C; Mehadji B; Roncali E; Chan CKF; Pratx G
bioRxiv; 2023 Sep; ():. PubMed ID: 37662335
[No Abstract] [Full Text] [Related]
3. Whole-Body [
Berzaczy D; Fueger B; Hoeller C; Haug AR; Staudenherz A; Berzaczy G; Weber M; Mayerhoefer ME
Mol Imaging Biol; 2020 Jun; 22(3):739-744. PubMed ID: 31363965
[TBL] [Abstract][Full Text] [Related]
4. Comparison of whole body magnetic resonance imaging (WBMRI) to whole body computed tomography (WBCT) or
Gariani J; Westerland O; Natas S; Verma H; Cook G; Goh V
Crit Rev Oncol Hematol; 2018 Apr; 124():66-72. PubMed ID: 29548488
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
[TBL] [Abstract][Full Text] [Related]
6. [
Rizzo-Padoin N; Chaussard M; Vignal N; Kotula E; Tsoupko-Sitnikov V; Vaz S; Hontonnou F; Liu WQ; Poyet JL; Vidal M; Merlet P; Hosten B; Sarda-Mantel L
Nucl Med Biol; 2016 Dec; 43(12):773-780. PubMed ID: 27693672
[TBL] [Abstract][Full Text] [Related]
7. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G
Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
[TBL] [Abstract][Full Text] [Related]
8. Detecting Pulmonary Nodules in Lung Cancer Patients Using Whole Body FDG PET/CT, High-resolution Lung Reformat of FDG PET/CT, or Diagnostic Breath Hold Chest CT.
Flavell RR; Behr SC; Mabray MC; Hernandez-Pampaloni M; Naeger DM
Acad Radiol; 2016 Sep; 23(9):1123-9. PubMed ID: 27283073
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
Lee JW; Nam SB; Kim SJ
Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided detection and segmentation of malignant melanoma lesions on whole-body
Dirks I; Keyaerts M; Neyns B; Vandemeulebroucke J
Comput Methods Programs Biomed; 2022 Jun; 221():106902. PubMed ID: 35636357
[TBL] [Abstract][Full Text] [Related]
12. Staging Uveal Melanoma with Whole-Body Positron-Emission Tomography/Computed Tomography and Abdominal Ultrasound: Low Incidence of Metastatic Disease, High Incidence of Second Primary Cancers.
Cohen VML; Pavlidou E; DaCosta J; Arora AK; Szyszko T; Sagoo MS; Szlosarek P
Middle East Afr J Ophthalmol; 2018; 25(2):91-95. PubMed ID: 30122854
[TBL] [Abstract][Full Text] [Related]
13. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA
Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285
[TBL] [Abstract][Full Text] [Related]
14. Single-cell tracking with PET using a novel trajectory reconstruction algorithm.
Lee KS; Kim TJ; Pratx G
IEEE Trans Med Imaging; 2015 Apr; 34(4):994-1003. PubMed ID: 25423651
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
16. The value of lymph node ultrasound and whole body
Stahlie EHA; van der Hiel B; Bruining A; van de Wiel B; Schrage YM; Wouters MWJM; van Houdt WJ; van Akkooi ACJ
Eur J Surg Oncol; 2021 May; 47(5):1157-1162. PubMed ID: 33353826
[TBL] [Abstract][Full Text] [Related]
17. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of whole body
Bower N; Morris A; O'Connor J; Sponagle M; Bahr R; Gilbert R; Mohamed A; Bower J
J Med Imaging Radiat Sci; 2024 Jun; 55(2):212-220. PubMed ID: 38403520
[TBL] [Abstract][Full Text] [Related]
19. Whole-Body
Lebech AM; Gaardsting A; Loft A; Graff J; Markova E; Bertelsen AK; Madsen JL; Andersen KF; Benzon EV; Helms M; Mathiesen LR; David KP; Kronborg G; Kjaer A
J Nucl Med; 2017 Jul; 58(7):1058-1064. PubMed ID: 28082437
[TBL] [Abstract][Full Text] [Related]
20. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
Schaarschmidt BM; Grueneisen J; Stebner V; Klode J; Stoffels I; Umutlu L; Schadendorf D; Heusch P; Antoch G; Pöppel TD
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
